After Reaching Milestone, Is BIOMERIEUX 69 MARCY LETOILE ORD (OTCMKTS:BMXMF)’s Short Interest Revealing Something?

January 13, 2018 - By Clifton Ray

The stock of BIOMERIEUX 69 MARCY LETOILE ORD (OTCMKTS:BMXMF) registered an increase of 106.34% in short interest. BMXMF’s total short interest was 58,600 shares in January as published by FINRA. Its up 106.34% from 28,400 shares, reported previously. With 100 shares average volume, it will take short sellers 586 days to cover their BMXMF’s short positions.

The stock increased 1.96% or $1.85 during the last trading session, reaching $96.25. About 15 shares traded. bioMérieux S.A. (OTCMKTS:BMXMF) has 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

bioMérieux S.A. provides in vitro diagnostics solutions that determine the source of disease and contamination to enhance patient health and consumer safety worldwide. The company has market cap of $11.30 billion. The firm offers reagents, instruments, software, and services for diagnosing infectious diseases, healthcare-associated infections, antimicrobial resistance, sepsis, acquired immunodeficiency syndrome, hepatitis, acute care and cardiovascular emergencies, and cancer; and for detecting microorganisms in agri-food, pharmaceutical, biotechnology, and cosmetic products. It has a 48.59 P/E ratio. The Company’s technologies and systems include clinical microbiology products, such as automated VITEK 2 system and Etest for the identification of bacteria and analysis of their susceptibility to antibiotics; VITEK MS, a mass spectrometry system for the identification of bacteria, fungi, and mycobacteria; culture media products; BacT/ALERT for the culture and detection of bacteria present in blood; lab solutions; and molecular diagnostics products.

More important recent bioMérieux S.A. (OTCMKTS:BMXMF) news were published by: which released: “bioMérieux – First-Half 2017 Results” on August 30, 2017, also published article titled: “bioMérieux – Business review for the nine months ended September 30, 2017”, published: “After $60M expansion, bioMérieux ready to ramp up production” on October 06, 2017. More interesting news about bioMérieux S.A. (OTCMKTS:BMXMF) was released by: and their article: “Alexandre Mérieux Appointed Chairman and CEO of bioMérieux” with publication date: December 15, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.